Pulmatrix
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Pulmatrix and other ETFs, options, and stocks.About PULM
Pulmatrix, Inc. is a clinical stage biotechnology company, which engages in the development and discovery of novel inhaled therapeutics products. The company was founded by David Alan Edwards, Mark J.
CEOPeter B. Ludlum
CEOPeter B. Ludlum
Employees2
Employees2
HeadquartersFramingham, Massachusetts
HeadquartersFramingham, Massachusetts
Founded2003
Founded2003
Employees2
Employees2
PULM Key Statistics
Market cap9.48M
Market cap9.48M
Price-Earnings ratio-1.51
Price-Earnings ratio-1.51
Dividend yield—
Dividend yield—
Average volume10.59K
Average volume10.59K
High today$2.64
High today$2.64
Low today$2.57
Low today$2.57
Open price$2.59
Open price$2.59
Volume4.63K
Volume4.63K
52 Week high$10.40
52 Week high$10.40
52 Week low$2.15
52 Week low$2.15
Stock Snapshot
With a market cap of 9.48M, Pulmatrix(PULM) trades at $2.60. The stock has a price-to-earnings ratio of -1.51.
On 2026-02-02, Pulmatrix(PULM) stock traded between a low of $2.57 and a high of $2.64. Shares are currently priced at $2.60, which is +1.0% above the low and -1.7% below the high.
Pulmatrix(PULM) shares are trading with a volume of 4.63K, against a daily average of 10.59K.
In the last year, Pulmatrix(PULM) shares hit a 52-week high of $10.40 and a 52-week low of $2.15.
In the last year, Pulmatrix(PULM) shares hit a 52-week high of $10.40 and a 52-week low of $2.15.
People also own
Based on the portfolios of people who own PULM. This list is generated using Robinhood data, and it’s not a recommendation.